Neurology – Dementia, Parkinsons

Untreated High Blood Pressure in Older Adults Linked to Dementia Risk

Untreated High Blood Pressure in Older Adults Linked to Dementia Risk

What Did the Research Discover? This large-scale meta-analysis examined data from 34,519 older adults across 17 population-based studies conducted in 15 different countries, including the United States, Brazil, Australia, China, and several European and African nations. The goal of the study was to determine whether hypertension and its treatment in late life...

Could Parkinson’s Disease Risk Be Lowed By Diabetes Drugs

Could Parkinson’s Disease Risk Be Lowed By Diabetes Drugs

What Did the Research Discover? Researchers conducted a meta-analysis of 24 randomized placebo-controlled trials to determine if newer glucose-lowering drugs (GLDs), including DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors, are associated with a lower risk of Parkinson’s disease (PD). The study analyzed 185,305 participants over a median follow-up...

Can Diabetes Drugs Lower Parkinson’s Risk?

Can Diabetes Drugs Lower Parkinson’s Risk?

Can medications for type 2 diabetes also protect the brain? A new meta-analysis published in Movement Disorders Clinical Practice combined results from 24 clinical trials—and found a possible link between newer diabetes medications and a lower risk of Parkinson’s disease.

The Future of Alzheimer’s Drugs: What Treatments Exist Now and What’s Coming Next

The Future of Alzheimer’s Drugs: What Treatments Exist Now and What’s Coming Next

Alzheimer’s disease is one of the biggest health challenges of our time. Millions of people and their families live with it, and while current treatments help, they are not a cure. Researchers around the world are working hard to find better ways to treat and slow the disease. This article explains what Alzheimer’s is, what treatments are available today, how...

Are Low Vitamin D Levels Associated with the Development and Relapses of Mulitple Sclerosis?

Are Low Vitamin D Levels Associated with the Development and Relapses of Mulitple Sclerosis?

What Did the Research Discover? This study explored whether vitamin D levels influence the risk of developing multiple sclerosis (MS) and its progression. Research from observational studies, epidemiological data, and genetic analyses suggests a strong link between lower vitamin D levels and increased MS risk and disease activity. Findings indicate that individuals...

Understanding Dementia Risk in Parkinson’s Disease: What the Latest Research Reveals

Understanding Dementia Risk in Parkinson’s Disease: What the Latest Research Reveals

What did the research discover? This research investigated how frequently patients with Parkinson’s disease (PD) develop dementia, a feared long-term outcome. Older studies suggested that up to 80% of PD patients develop dementia, but this study used more recent data from two large research cohorts to provide a clearer picture. The study followed 417 participants...